These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 38279217

  • 41. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
    Tan Z, Xiao L, Tang M, Bai F, Li J, Li L, Shi F, Li N, Li Y, Du Q, Lu J, Weng X, Yi W, Zhang H, Fan J, Zhou J, Gao Q, Onuchic JN, Bode AM, Luo X, Cao Y.
    Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
    [Abstract] [Full Text] [Related]

  • 42. Targeting myocardial substrate metabolism in heart failure: potential for new therapies.
    Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, Cleland JG, Maggioni A, Fonarow GC, Abel ED, Campia U, Gheorghiade M.
    Eur J Heart Fail; 2012 Feb; 14(2):120-9. PubMed ID: 22253453
    [Abstract] [Full Text] [Related]

  • 43. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR, Carley AN, Ji R, Zhang X, Fasano M, Schulze PC, Lewandowski ED.
    Circulation; 2019 Jun 11; 139(24):2765-2777. PubMed ID: 30909726
    [Abstract] [Full Text] [Related]

  • 44. Targeting mitochondrial oxidative metabolism as an approach to treat heart failure.
    Fillmore N, Lopaschuk GD.
    Biochim Biophys Acta; 2013 Apr 11; 1833(4):857-65. PubMed ID: 22960640
    [Abstract] [Full Text] [Related]

  • 45. Energetics and metabolism in the failing heart: important but poorly understood.
    Turer AT, Malloy CR, Newgard CB, Podgoreanu MV.
    Curr Opin Clin Nutr Metab Care; 2010 Jul 11; 13(4):458-65. PubMed ID: 20453645
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Diabetic db/db mice do not develop heart failure upon pressure overload: a longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
    Abdurrachim D, Nabben M, Hoerr V, Kuhlmann MT, Bovenkamp P, Ciapaite J, Geraets IME, Coumans W, Luiken JJFP, Glatz JFC, Schäfers M, Nicolay K, Faber C, Hermann S, Prompers JJ.
    Cardiovasc Res; 2017 Aug 01; 113(10):1148-1160. PubMed ID: 28549111
    [Abstract] [Full Text] [Related]

  • 49. Cardiac lipid metabolism, mitochondrial function, and heart failure.
    Da Dalt L, Cabodevilla AG, Goldberg IJ, Norata GD.
    Cardiovasc Res; 2023 Aug 19; 119(10):1905-1914. PubMed ID: 37392421
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Prohibitin 2 deficiency impairs cardiac fatty acid oxidation and causes heart failure.
    Wu D, Jian C, Peng Q, Hou T, Wu K, Shang B, Zhao M, Wang Y, Zheng W, Ma Q, Li CY, Cheng H, Wang X, Zhao L.
    Cell Death Dis; 2020 Mar 12; 11(3):181. PubMed ID: 32165613
    [Abstract] [Full Text] [Related]

  • 52. Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?
    Yurista SR, Chen S, Welsh A, Tang WHW, Nguyen CT.
    Curr Heart Fail Rep; 2022 Aug 12; 19(4):180-190. PubMed ID: 35567658
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Metabolic remodelling of the failing heart: beneficial or detrimental?
    van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ.
    Cardiovasc Res; 2009 Feb 15; 81(3):420-8. PubMed ID: 18854380
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. A mitochondrial long-chain fatty acid oxidation defect leads to transfer RNA uncharging and activation of the integrated stress response in the mouse heart.
    Ranea-Robles P, Pavlova NN, Bender A, Pereyra AS, Ellis JM, Stauffer B, Yu C, Thompson CB, Argmann C, Puchowicz M, Houten SM.
    Cardiovasc Res; 2022 Dec 29; 118(16):3198-3210. PubMed ID: 35388887
    [Abstract] [Full Text] [Related]

  • 57. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
    Ritchie RH, Zerenturk EJ, Prakoso D, Calkin AC.
    J Mol Endocrinol; 2017 May 29; 58(4):R225-R240. PubMed ID: 28373293
    [Abstract] [Full Text] [Related]

  • 58. Nuclear receptor signaling and cardiac energetics.
    Huss JM, Kelly DP.
    Circ Res; 2004 Sep 17; 95(6):568-78. PubMed ID: 15375023
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. RIP140 deficiency enhances cardiac fuel metabolism and protects mice from heart failure.
    Yamamoto T, Maurya SK, Pruzinsky E, Batmanov K, Xiao Y, Sulon SM, Sakamoto T, Wang Y, Lai L, McDaid KS, Shewale SV, Leone TC, Koves TR, Muoio DM, Dierickx P, Lazar MA, Lewandowski ED, Kelly DP.
    J Clin Invest; 2023 May 01; 133(9):. PubMed ID: 36927960
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.